B Cell Test Predicts Alemtuzumab Autoimmunity in MS

Analyzing B cell counts before treatment could help select patients for the drug, a new study suggests.
Medscape Medical News

Source link

Related posts

Effect of polygenic load on striatal dopaminergic deterioration in Parkinson disease


What's happening in Neurology(R) Neuroimmunology & Neuroinflammation


OnabotulinumtoxinA for Post-Stroke Spasticity: Treatment Strategies and Limitations


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World